✦ LIBER ✦

PGI20 Cost-Effectiveness of Adalimumab for Treatment of Crohn's Disease in Germany

✍ Scribed by M. Yang; M. Yang; M. Skup; Z.Y. Zhou; N. Hengst; M. Wolff; P.M. Mulani; J. Chao

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PGI2 Cost-Effectiveness Analysis of the

✍ Mayen-Herrera, E.; Pozos, J.C.; Yang, M.; Cortina, D. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PGI7 COST-EFFECTIVENESS ANALYSIS OF ADAL

✍ S Johnson; A Kaltenboeck; C Horn; P Mulani; S Majethia; J Chao 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PGI11 ECONOMIC EVALUATION OF INFLIXIMAB

✍ DA Hughes; T Kikuchi; K Bodger 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Comparative Effectiveness of Infliximab

✍ Osterman, Mark T.; Haynes, Kevin; Delzell, Elizabeth; Zhang, Jie; Bewtra, Meenak 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 226 KB

W1289 Effectiveness of Adalimumab for th

✍ Barreiro, Manuel; Lorenzo, Aurelio; Seoane, Montserrat; Dominguez-Munoz, Enrique 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Adalimumab makes GAINs in treatment of C

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB